Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis.
IL-34
M-CSF
ligature-induced periodontitis
monoclonal antibody
osteoclast precursors
osteoclastogenesis
Journal
Molecular oral microbiology
ISSN: 2041-1014
Titre abrégé: Mol Oral Microbiol
Pays: Denmark
ID NLM: 101524770
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
revised:
19
09
2023
received:
31
05
2023
accepted:
21
09
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
aheadofprint
Résumé
Macrophage colony-stimulating factor (M-CSF) and interleukin-34 (IL-34) are ligands for the colony-stimulating factor-1 receptor (CSF-1r) expressed on the surface of monocyte/macrophage lineage cells. The importance of coordinated signaling between M-CSF/receptor activator of the nuclear factor kappa-Β ligand (RANKL) in physiological and pathological bone remodeling and alveolar bone loss in response to oral bacterial colonization is well established. However, our knowledge about the IL-34/RANKL signaling in periodontal bone loss remains limited. Recently published cohort studies have demonstrated that the expression patterns of IL-34 are dramatically elevated in gingival crevicular fluid collected from patients with periodontitis. Therefore, the present study aims to evaluate the effects of IL-34 on osteoclastogenesis in vitro and in experimental ligature-mediated model of periodontitis using male mice. Our initial in vitro study demonstrated increased RANKL-induced osteoclastogenesis of IL-34-primed osteoclast precursors (OCPs) compared to M-CSF-primed OCPs. Using an experimental model of ligature-mediated periodontitis, we further demonstrated elevated expression of IL-34 in periodontal lesions. In contrast, M-CSF levels were dramatically reduced in these periodontal lesions. Furthermore, local injections of mouse recombinant IL-34 protein significantly elevated cathepsin K activity, increased the number of tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts and promoted alveolar bone loss in periodontitis lesions. In contrast, anti-IL-34 neutralizing monoclonal antibody significantly reduced the level of alveolar bone loss and the number of TRAP-positive osteoclasts in periodontitis lesions. No beneficial effects of locally injected anti-M-CSF neutralizing antibody were observed in periodontal lesions. This study illustrates the role of IL-34 in promoting alveolar bone loss in periodontal lesions and proposes the potential of anti-IL34 monoclonal antibody (mAb)-based therapeutic regimens to suppress alveolar bone loss in periodontitis lesions.
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIDCR NIH HHS
Pays : United States
Organisme : NIA NIH HHS
Pays : United States
Informations de copyright
© 2023 The Authors. Molecular Oral Microbiology published by John Wiley & Sons Ltd.
Références
Adamopoulos, I. E., & Mellins, E. D. (2015). Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nature Reviews Rheumatology, 11(3), 189-194. https://doi.org/10.1038/nrrheum.2014.198
Akkaoui, J., Yamada, C., Duarte, C., Ho, A., Vardar-Sengul, S., Kawai, T., & Movila, A. (2021). Contribution of Porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to aging. Geroscience, 43(1), 367-376. https://doi.org/10.1007/s11357-020-00258-1
Almarghlani, A., Settem, R. P., Croft, A. J., Metcalfe, S., Giangreco, M., & Kay, J. G. (2022). Interleukin-34 permits Porphyromonas gingivalis survival and NF-kappaB p65 inhibition in macrophages. Molecular Oral Microbiology, 37(3), 109-121. https://doi.org/10.1111/omi.12366
Baghdadi, M., Ishikawa, K., Nakanishi, S., Murata, T., Umeyama, Y., Kobayashi, T., Kameda, Y., Endo, H., Wada, H., Bogen, B., Yamamoto, S., Yamaguchi, K., Kasahara, I., Iwasaki, H., Takahata, M., Ibata, M., Takahashi, S., Goto, H., Teshima, T., & Seino, K. I. (2019). A role for IL-34 in osteolytic disease of multiple myeloma. Blood Advances, 3(4), 541-551. https://doi.org/10.1182/bloodadvances.2018020008
Batra, P., Das, S., & Patel, P. (2019). Comparative evaluation of gingival crevicular fluid (GCF) levels of interleukin-34 levels in periodontally healthy and in patients with chronic and aggressive periodontitis-A cross-sectional study. The Saudi Dental Journal, 31(3), 316-321. https://doi.org/10.1016/j.sdentj.2019.03.010
Baud'huin, M., Renault, R., Charrier, C., Riet, A., Moreau, A., Brion, R., Gouin, F., Duplomb, L., & Heymann, D. (2010). Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. Journal of Pathology, 221(1), 77-86. https://doi.org/10.1002/path.2684
Bostrom, E. A., & Lundberg, P. (2013). The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PLoS ONE, 8(12), e81665. https://doi.org/10.1371/journal.pone.0081665
Boyce, B. F., & Xing, L. (2008). Functions of RANKL/RANK/OPG in bone modeling and remodeling. Archives of Biochemistry and Biophysics, 473(2), 139-146. https://doi.org/10.1016/j.abb.2008.03.018
Boyer, E., Martin, B., Le Gall-David, S., Fong, S. B., Deugnier, Y., Bonnaure-Mallet, M., & Meuric, V. (2020). Periodontal pathogens and clinical parameters in chronic periodontitis. Molecular Oral Microbiology, 35(1), 19-28. https://doi.org/10.1111/omi.12274
Bozkurt Dogan, S., Ongoz Dede, F., Balli, U., & Sertoglu, E. (2021). Emerging roles of interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease. Cytokine, 144, 155584. https://doi.org/10.1016/j.cyto.2021.155584
Bravo-Lopez, M., Villa-Islas, V., Rocha Arriaga, C., Villasenor-Altamirano, A. B., Guzman-Solis, A., Sandoval-Velasco, M., Wesp, J. K., Alcantara, K., López-Corral, A., Gómez-Valdés, J., Mejía, E., Herrera, A., Meraz-Moreno, A., Moreno-Cabrera, M. de la L., Moreno-Estrada, A., Nieves-Colón, M. A., Olvera, J., Pérez-Pérez, J., Iversen, K. H., … Avila-Arcos, M. C. (2020). Paleogenomic insights into the red complex bacteria Tannerella forsythia in Pre-Hispanic and Colonial individuals from Mexico. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 375(1812), 20190580. https://doi.org/10.1098/rstb.2019.0580
Chemel, M., Le Goff, B., Brion, R., Cozic, C., Berreur, M., Amiaud, J., Bougras, G., Touchais, S., Blanchard, F., Heymann, M. F., Berthelot, J. M., Verrecchia, F., & Heymann, D. (2012). Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 71(1), 150-154. https://doi.org/10.1136/annrheumdis-2011-200096
Chen, Z., Buki, K., Vaaraniemi, J., Gu, G., & Vaananen, H. K. (2011). The critical role of IL-34 in osteoclastogenesis. PLoS ONE, 6(4), e18689. https://doi.org/10.1371/journal.pone.0018689
Chihara, T., Suzu, S., Hassan, R., Chutiwitoonchai, N., Hiyoshi, M., Motoyoshi, K., Kimura, F., & Okada, S. (2010). IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death and Differentiation, 17(12), 1917-1927. https://doi.org/10.1038/cdd.2010.60
Clark, R., Zwicker, S., Bureik, D., Johannsen, G., & Bostrom, E. A. (2020). Expression of colony-stimulating factor 1 and interleukin-34 in gingival tissue and gingival fibroblasts from periodontitis patients and controls. Journal of Periodontology, 91(6), 828-835. https://doi.org/10.1002/JPER.19-0296
Dai, X. M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002). Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood, 99(1), 111-120. https://doi.org/10.1182/blood.v99.1.111
Dikilitas, A., Karaaslan, F., Evirgen, S., & Ertugrul, A. S. (2022). Gingival crevicular fluid CSF-1 and IL-34 levels in patients with stage III grade C periodontitis and uncontrolled type 2 diabetes mellitus. Journal of Periodontal & Implant Science, 52(6), 455-465. https://doi.org/10.5051/jpis.2106260313
Duarte, C., Akkaoui, J., Ho, A., Garcia, C., Yamada, C., & Movila, A. (2021). Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro. Biochemical and Biophysical Research Communications, 546, 97-102. https://doi.org/10.1016/j.bbrc.2021.01.104
Duarte, C., Yamada, C., Garcia, C., Akkaoui, J., Ho, A., Nichols, F., & Movila, A. (2022). Crosstalk between dihydroceramides produced by Porphyromonas gingivalis and host lysosomal cathepsin B in the promotion of osteoclastogenesis. Journal of Cellular and Molecular Medicine, 26(10), 2841-2851. https://doi.org/10.1111/jcmm.17299
Eke, P. I., Dye, B. A., Wei, L., Slade, G. D., Thornton-Evans, G. O., Borgnakke, W. S., Taylor, G. W., Page, R. C., Beck, J. D., & Genco, R. J. (2015). Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. Journal of Periodontology, 86(5), 611-622. https://doi.org/10.1902/jop.2015.140520
Franze, E., Stolfi, C., Troncone, E., Scarozza, P., & Monteleone, G. (2020). Role of interleukin-34 in Cancer. Cancers (Basel), 12(1), 252. https://doi.org/10.3390/cancers12010252
Goncalves, P. F., Harris, T. H., Elmariah, T., Aukhil, I., Wallace, M. R., & Shaddox, L. M. (2018). Genetic polymorphisms and periodontal disease in populations of African descent: A review. Journal of Periodontal Research, 53(2), 164-173. https://doi.org/10.1111/jre.12505
Guruprasad, C., & Pradeep, A. (2018a). Interleukin-34 levels in gingival crevicular fluid and plasma in periodontal health and disease with and without type-2 diabetes mellitus. Journal of Investigative and Clinical Dentistry, 9(2), e12317. https://doi.org/10.1111/jicd.12317
Guruprasad, C. N., & Pradeep, A. R. (2018b). Effect of nonsurgical periodontal therapy on interleukin-34 levels in periodontal health and disease. Indian Journal of Dental Research, 29(3), 280-285. https://doi.org/10.4103/ijdr.IJDR_527_17
Hernandez, M., Phulpin, B., Mansuy, L., & Droz, D. (2016). Use of new targeted cancer therapies in children: Effects on dental development and risk of jaw osteonecrosis: A review. Journal of Oral Pathology & Medicine, 46(5), 321-326. https://doi.org/10.1111/jop.12516
Hienz, S. A., Paliwal, S., & Ivanovski, S. (2015). Mechanisms of bone resorption in periodontitis. Journal of Immunology Research, 2015, 1. https://doi.org/10.1155/2015/615486
Ho, A., Ngala, B., Yamada, C., Garcia, C., Duarte, C., Akkaoui, J., Ciolac, D., Nusbaum, A., Kochen, W., Efremova, D., Groppa, S., Nathanson, L., Bissel, S., Oblak, A., Kacena, M. A., & Movila, A. (2023). IL-34 exacerbates pathogenic features of Alzheimer's disease and Calvaria osteolysis in triple transgenic (3x-Tg) female mice. Biomedicine & Pharmacotherapy, 166, 115435. https://doi.org/10.1016/j.biopha.2023.115435
Hwang, S. J., Choi, B., Kang, S. S., Chang, J. H., Kim, Y. G., Chung, Y. H., Sohn, D., So, M., Lee, C.-K., Robinson, W. H., & Chang, E. J. (2012). Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Research & Therapy, 14(1), R14. https://doi.org/10.1186/ar3693
Kanzaki, H., Makihira, S., Suzuki, M., Ishii, T., Movila, A., Hirschfeld, J., Mawardi, H., Lin, X., Han, X., Taubman, M. A., & Kawai, T. (2016). Soluble RANKL cleaved from activated lymphocytes by TNF-alpha-converting enzyme contributes to osteoclastogenesis in periodontitis. Journal of Immunology, 197(10), 3871-3883. https://doi.org/10.4049/jimmunol.1601114
Kurotaki, D., Yoshida, H., & Tamura, T. (2020). Epigenetic and transcriptional regulation of osteoclast differentiation. Bone, 138, 115471. https://doi.org/10.1016/j.bone.2020.115471
Lelios, I., Cansever, D., Utz, S. G., Mildenberger, W., Stifter, S. A., & Greter, M. (2020). Emerging roles of IL-34 in health and disease. Journal of Experimental Medicine, 217(3), e20190290. https://doi.org/10.1084/jem.20190290
Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., Hollenbaugh, D., Linnemann, T., Qin, M., Wong, J., Chu, K., Doberstein, S. K., & Williams, L. T. (2008). Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science, 320(5877), 807-811. https://doi.org/10.1126/science.1154370
Lin, P., Niimi, H., Ohsugi, Y., Tsuchiya, Y., Shimohira, T., Komatsu, K., Liu, A., Shiba, T., Aoki, A., Iwata, T., & Katagiri, S. (2021). Application of ligature-induced periodontitis in mice to explore the molecular mechanism of periodontal disease. International Journal of Molecular Sciences, 22(16), 8900. https://doi.org/10.3390/ijms22168900
Liu, H., Leo, C., Chen, X., Wong, B. R., Williams, L. T., Lin, H., & He, X. (2012). The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochimica Et Biophysica Acta, 1824(7), 938-945. https://doi.org/10.1016/j.bbapap.2012.04.012
Luo, Y., Ding, Y., & Chen, Y. (2023). The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis. Open Life Sciences, 18(1), 20220563. https://doi.org/10.1515/biol-2022-0563
Matsuda, S., Movila, A., Suzuki, M., Kajiya, M., Wisitrasameewong, W., Kayal, R., Hirshfeld, J., Al-dharrab, A., Savitri, I. J., Mira, A., Kurihara, H., Taubman, M. A., & Kawai, T. (2016). A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis. Journal of Immunological Methods, 438, 21-25. https://doi.org/10.1016/j.jim.2016.08.008
Movila, A., Ishii, T., Albassam, A., Wisitrasameewong, W., Howait, M., Yamaguchi, T., Ruiz-Torruella, M., Bahammam, L., Nishimura, K., Van Dyke, T., & Kawai, T. (2016). Macrophage migration inhibitory factor (MIF) supports homing of osteoclast precursors to peripheral osteolytic lesions. Journal of Bone and Mineral Research, 31(9), 1688-1700. https://doi.org/10.1002/jbmr.2854
Mun, S. H., Park, P. S. U., & Park-Min, K. H. (2020). The M-CSF receptor in osteoclasts and beyond. Experimental & Molecular Medicine, 52(8), 1239-1254. https://doi.org/10.1038/s12276-020-0484-z
Nakamichi, Y., Mizoguchi, T., Arai, A., Kobayashi, Y., Sato, M., Penninger, J. M., Yasuda, H., Kato, S., DeLuca, H. F., Suda, T., Udagawa, N., & Takahashi, N. (2012). Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice. PNAS, 109(25), 10006-10011. https://doi.org/10.1073/pnas.1207361109
Obst, J., Simon, E., Martin-Estebane, M., Pipi, E., Barkwill, L. M., Gonzalez-Rivera, I., Buchanan, F., Prescott, A. R., Faust, D., Fox, S., Brownlees, J., Taylor, D., Perry, V. H., Nuthall, H., Atkinson, P. J., Karran, E., Routledge, C., & Gomez-Nicola, D. (2020). Inhibition of IL-34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in a model of chronic neurodegeneration. Frontiers in Immunology, 11, 579000. https://doi.org/10.3389/fimmu.2020.579000
Park-Min, K. H. (2018). Mechanisms involved in normal and pathological osteoclastogenesis. Cellular and Molecular Life Sciences, 75(14), 2519-2528. https://doi.org/10.1007/s00018-018-2817-9
Pereira, M., Petretto, E., Gordon, S., Bassett, J. H. D., Williams, G. R., & Behmoaras, J. (2018). Common signalling pathways in macrophage and osteoclast multinucleation. Journal of Cell Science, 131(11), jcs216267. https://doi.org/10.1242/jcs.216267
Pettit, A. R., Ji, H., von Stechow, D., Muller, R., Goldring, S. R., Choi, Y., Benoist, C., & Gravallese, E. M. (2001). TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. American Journal of Pathology, 159(5), 1689-1699. https://doi.org/10.1016/S0002-9440(10)63016-7
Robling, A. G., & Bonewald, L. F. (2020). The osteocyte: New insights. Annual Review of Physiology, 82, 485-506. https://doi.org/10.1146/annurev-physiol-021119-034332
Roodman, G. D. (2006). Regulation of osteoclast differentiation. Annals of the New York Academy of Sciences, 1068, 100-109. https://doi.org/10.1196/annals.1346.013
Scolnik, P. A. (2009). mAbs: A business perspective. mAbs, 1(2), 179-184. https://doi.org/10.4161/mabs.1.2.7736
Segaliny, A. I., Mohamadi, A., Dizier, B., Lokajczyk, A., Brion, R., Lanel, R., Amiaud, J., Charrier, C., Boisson-Vidal, C., & Heymann, D. (2015). Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. International Journal of Cancer, 137(1), 73-85. https://doi.org/10.1002/ijc.29376
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W. Jr., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., & Stanley, E. R. (1990). Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proceedings of the National Academy of Sciences of the United States of America, 87(12), 4828-4832. https://doi.org/10.1073/pnas.87.12.4828
Wisitrasameewong, W., Kajiya, M., Movila, A., Rittling, S., Ishii, T., Suzuki, M., Matsuda, S., Mazda, Y., Torruella, M. R., Azuma, M. M., Egashira, K., Freire, M. O., Sasaki, H., Wang, C. Y., Han, X., Taubman, M. A., & Kawai, T. (2017). DC-STAMP is an Osteoclast Fusogen engaged in periodontal bone resorption. Journal of Dental Research, 96(6), 685-693. https://doi.org/10.1177/0022034517690490
Yamada, C., Ho, A., Akkaoui, J., Garcia, C., Duarte, C., & Movila, A. (2021). Glycyrrhizin mitigates inflammatory bone loss and promotes expression of senescence-protective sirtuins in an aging mouse model of periprosthetic osteolysis. Biomedicine & Pharmacotherapy, 138, 111503. https://doi.org/10.1016/j.biopha.2021.111503
Zhang, X., Hu, Z., Zhu, X., Li, W., & Chen, J. (2020). Treating periodontitis-a systematic review and meta-analysis comparing ultrasonic and manual subgingival scaling at different probing pocket depths. BMC Oral Health, 20(1), 176. https://doi.org/10.1186/s12903-020-01117-3